Delivery Order SPE2DB22D3016-SPE2DB25FAVX3

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has a ceiling value of $3,551.65 and an ultimate completion date of July 18, 2024. This is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,280.57 fixed-price contract is for the supply of febuxostat 40 mg tablets, a medication used to treat gout. The contract has an ultimate completion date of July 26, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Febuxostat 40 mg tablets, a generic medication used to treat gout. The delivery order has a firm fixed price of $1,253.33 and a completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has a ceiling value of $1,401.63 and runs through June 12, 2024. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.73, is a Firm Fixed Price Delivery Order for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Febuxostat 40 mg tablets, a medication used to treat gout. The contract has a ceiling value of $8,793.61 and was awarded on July 18, 2022, with a completion date of July 19, 2022. The contract is a firm fixed-price delivery order, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of febuxostat 40 mg tablets. The contract has a ceiling value of $17,032.46 and a period of performance through August 1, 2024. It is a firm-fixed price delivery order contract, with no set-aside designation. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a $1,500.85 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Febuxostat 80 mg tablets, which are used to treat gout. The contract is a firm fixed-price delivery order and does not have any set-aside designation, indicating it was awarded through open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Febuxostat 40 mg tablets, with a ceiling value of $2,408.89 and a performance period through May 12, 2023. The contract is an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a $1,306.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FEBUXOSTAT 80 MG TABLET 30S, a medication used to treat gout. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAVX3
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 40 mg Febuxostat tablets, a medication used to treat gout. The contract has a ceiling value of $1,787.48 and a performance period ending on May 8, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/6/25, 9:53 AM